Radiation and Environmental Biophysics

, Volume 57, Issue 1, pp 77–82 | Cite as

Measurement of 131I activity in air indoor Polish nuclear medical hospital as a tool for an internal dose assessment

  • K. BrudeckiEmail author
  • A. Szczodry
  • T. Mróz
  • A. Kowalska
  • J. W. Mietelski
Open Access
Original Article


This paper presents results of 131I air activity measurements performed within nuclear medical hospitals as a tool for internal dose assessment. The study was conducted at a place of preparation and administration of 131I (“hot room”) and at a nurse station. 131I activity measurements were performed for 5 and 4 consecutive working days, at the “hot room” and nurse station, respectively. Iodine from the air was collected by a mobile HVS-30 aerosol sampler combined with a gas sampler. Both the gaseous and aerosol fractions were measurement. The activities in the gaseous fraction ranged from (28 ± 1 Bq m−3) to (492 ± 4) Bq m−3. At both sampling sites, the activity of the gaseous iodine fraction trapped on activated charcoal was significantly higher than that of the aerosol fraction captured on Petrianov filter cloth. Based on these results, an attempt has been made to estimate annual inhalation effective doses, which were found to range from 0.47 mSv (nurse female) to 1.3 mSv (technician male). The highest annual inhalation equivalent doses have been found for thyroid as 32, 27, 13, and 11 mSv, respectively, for technician male, technical female, nurse male, and nurse female. The method presented here allows to fill the gaps in internal doses measurements. Moreover, because method has been successful used for many years in radioactive contamination monitoring of air in cases of serious nuclear accidents, it should also be used in nuclear medicine.


131Air Nuclear medicine Medical personnel Equivalent and effective doses 


Among the radionuclides used in medical diagnostics and therapy, 131I is very popular; because it is a beta emitter, it has a short half-life (T 1/2 = 8.03 d) and it is selectively taken up by the thyroid. In the previous studies, we focused on measuring the activity of 131I in thyroids of nuclear medicine staff and calculating internal doses. For example, in 2016, the 131I thyroid activity was measured in 30 members of nuclear medicine personnel of the Department of Endocrinology and Nuclear Medicine Holycross Cancer Centre (E&NM HCC) in Kielce, Poland. Measurements were conducted using the Whole-Body Spectrometer (WBS) equipped with two HPGe detectors. 131I activity in thyroids was observed in ten individuals. The measured activities were found to vary between (5 ± 2) Bq and (217 ± 56) Bq. Estimated internal annual effective doses ranged from 0.02 to 0.8 mSv. The corresponding annual thyroid equivalent doses ranged from 0.4 to 15.5 mSv (Brudecki et al. 2017a).

The previous studies have shown that radiological protection of workers being only based on measurements with thermoluminescence detectors (TLDs) is insufficient. In such a case, exposures to the external nuclear radiation field are monitored, while those due to incorporated radionuclides are not. On the other hand, a WBS as a tool for evaluating internal doses is highly impractical, because it is an expensive and complex instrument, and its handling requires expert knowledge. At present in Poland, only two such devices are in operation, while there exist more than 60 nuclear medicine facilities using radioactive iodine. In principle, internal dose assessment can be also done by measuring 131I activity concentrations in the air within nuclear medical hospitals (ICRP 1997). Some results based on this approach were already published. For example, Hoi et al. (2017) reported measured average activity concentrations of 131I in the air of 815 ± 37 Bq m−3 resulting in effective doses for eight workers between 0.146 ± 0.004 and 3.052 ± 0.095 mSv. Measurements performed by Jiemwutthisak et al. (2012) in a nuclear medicine hospital showed 131I activity concentrations between 2.94 ± 3.60 Bq m−3 in a hospital ward waste collection area and 31.6 ± 16.3 Bq m−3 in a fume hood, where the iodine pills are taken out of the safety containers and prepared for patients. Results published by Ferdous et al. (2017) showed 131I activity concentrations from 0.19 to 60.67 Bq m−3 (uncertainties were not expressed) in the hot lab of a nuclear medicine facility.

The first step of the present study was to measure the 131I activity concentrations in the air of rooms used for radioiodine treatment, at the Department E&NM HCC in Kielce, Poland. A two-way monitoring system was applied in which activities of radioiodine associated with gaseous and aerosol fractions can be measured separately. As a second step, inhalation doses for medical personnel were estimated according to a methodology recommended by the International Commission on Radiological Protection (ICRP).

Materials and methods

Aerosol and gas sampling

Because gaseous and aerosol fractions of 131I activity in the air are not only from “hot rooms” (rooms prepared for handling Na131I pills), but may also be from patients (e.g., perspiration and breath) (Ibis et al. 1992), aerosol/gas activity was measured in samples collected from different locations within the investigated nuclear medicine facility located at the Department E&NM HCC in Kielce, Poland. 131I activity concentrations were measured in samples collected in a “hot room” and a nurse station. Measurements were performed for 5 and 4 consecutive working days, respectively, for the “hot room” and the nurse station.

For sample collection, a mobile aerosol sampler HVS-30 (produced by Atmoservice Ltd., Poznań, Poland) combined with a gas sampler was used (Mietelski et al. 2005). The HVS-30 aerosol sampler operated at a flow rate of 30 m3 h−1. The aerosol fraction was captured using a Petryanov filter FPP-15-1.5 [poly(vinyl chloride)], while the gas fraction was collected using granular-activated carbon as a sorbent (IBJ-6, mesh size 2 mm, produced by Gryskand, Hajnówka, Poland). The sampler and the filters are shown in Fig. 1. The carbon used was impregnated with KI which means that both organic and inorganic iodines were collected (Wilhelm 1982; Wangchang et al. 1993). Such a method has already been successfully applied for measurement of aerosol and gas activities (Mietelski et al. 2005, 2014, 2017; Masson et al. 2011). Before sampling, the charcoal was heated to 105 °C for 2 days to remove moisture. Then, the charcoal was sealed in plastic bags. After sampling, the charcoal was again placed in plastic bags and transported to the laboratory for gamma-ray spectrometry.

Fig. 1

Air sampler (a) and filters (b). 1—Petryanov filter, 2—first carbon cassette, 3—second carbon cassette

The charcoal was localized in two identical cassettes forming a single cartridge. The air was pumped through the cartridge, subsequently through the first and second cassettes. The same absorption yield is assumed for both cassettes; therefore, it can be assumed that the activity concentration in the cassettes forms geometrical series. Thus, the total activity concentration in the air \({C_{total}}\) can be calculated from the known formula (Eq. 1) as a sum of an infinite geometric series:
$${C_{{\text{total}}}}=\frac{{{C_A}}}{{1 - q}}$$

where \(q=\frac{{{C_A}}}{{{C_B}}}\), and \({C_A}\) and \({C_B}\) represent the activity concentrations measured in the first and second cassettes, respectively.

In such a case, the total efficiency \(\varepsilon\) of absorption can be calculated, as shown in
$$\varepsilon =1 - {q^2}.$$

To make sure that the samples can be considered representative, separated areas with normally functioning ventilation and air conditioning were chosen as sampling locations. Following recommendations of the International Atomic Energy Agency (IAEA), the sampling cartridge was mounted 1.6 m above the floor to collect the air from the breathing zone (IAEA 1999).

Gamma spectrometric analysis

For determination of 131I activity collected on charcoal and Petryanov filter cloth, the intensity of 364.46 kev gamma line was measured by means of a low-background gamma spectrometer including an HPGe detector. Before the Petryanov filters could be measured, they had to be compressed into a disc-shaped geometry of 5 cm diameter and about 4 mm height. The charcoal from each cassette was measured inside 0.5 L plastic Marinelli beakers. The efficiency calibration was determined with a multi-gamma source (SZN 40/10 provided by Polatom) and a standard mixed gamma source (SZM-3 provided by Polatom) for the filters and charcoal samples, respectively.

Doses estimation

Based on the measured 131I air activity concentrations, doses were estimated for the technicians and nurses, separately for the gas and aerosol fraction.

From the routine schemes of the medical staff and from survey questions, working times in the contaminated areas and breathing parameters were estimated. Normally, nurses work one 12-h shift every 3 days in the department, for 3 months in the year. Furthermore, 131I is administered to patients weekly on Fridays, so typically, the technicians spent between 4 and 8 h (depending on the patient number) per week in the “hot room”. Here, for the dose calculations, an average value of 6 h is assumed. In the present study, the human respiratory tract model published in ICRP (1994) was used. The breathing parameters assumed for the dose computations are presented in Table 1.

Table 1

Time budget, ventilation parameters, and activity concentrations assumed for the dose calculations




Exercise level



Breathing rate (m3 h−1)

0.39 (females), 0.54 (males)

Single intake time (h)



Single 131I gas fraction activity in the air (Bq m−3)



Single 131I aerosol fraction activity in the air (Bq m−3)



Intake frequency

Once a week (on Friday)

Every 3 days

Number of intakes per year



Unfortunately, the measuring equipment used in the present study did not allow measurement of aerosol diameters. Therefore, the deposition of 131I aerosol fractions was calculated for an assumed activity median aerodynamic diameter (AMADs) of the attached aerosols of 5 µm, following the ICRP recommendation for workers. Deposition of the gas fraction was calculated for elemental iodine (100% deposition in the respiratory tract, 10% in the extrathoracic region—ET1, 40% in posterior nasal passages—ET2, and 50% in the bronchial region—BB) (ICRP 1995). Both simplifications resulted in an overestimation of the calculated doses which is, however, in line with the so-called conservative assessment rule, where doses should be over-rather than underestimated. Details on deposition parameters are presented in Table 2.

Table 2

Deposition parameters used in the present study (ICRP 1995, 2002)


5 µm AMAD and sitting subjects


Adult male

Adult female

Adult male

Adult female


2.80 × 10− 1

2.70 × 10− 1

1.00 × 10− 1


3.40 × 10− 1

3.30 × 10− 1

4.00 × 10− 1

BB fast and seq

1.20 × 10− 2

1.10 × 10− 2

5.00 × 10− 1

BB slow

4.30 × 10− 3

3.90 × 10− 3

bb fast and seq

1.50 × 10− 2

1.80 × 10− 2


bb slow

8.70 × 10− 3

1.00 × 10− 2


1.00 × 10− 1

9.40 × 10− 2


AMAD activity median aerodynamic diameter, ET 1 extrathoracic region, ET 2 posterior nasal passages, BB bronchial region, bb bronchiolar region, AI alveolar–interstitial region

Doses were calculated based on the time-integrated 131I activity, radiation-weighted coefficients (S w), and tissue-weighting factors (w T) according to the ICRP methodology. The time-integrated 131I activity was obtained from computer biokinetic modeling. Here, the iodine biokinetic model developed by Leggett (2010) was combined with the human respiratory tract model (ICRP 1994, 2002) and gastro-intestinal tract model (ICRP 1979) developed by ICRP. The SAAM II software (Epsilon Group, VA, USA) was used for the calculations. This overall methodology has already been successfully applied previously (Brudecki et al. 2014, 2017a, b; Li et al. 2008). The radiation-weighted S w coefficients were calculated separately for males and females, with the SEECAL program (Oak Ridge National Laboratory, Oak Ridge, TN, USA). Tissue-weighting factors, wT, were taken from ICRP 103 (2007).

Results and discussion

At both sampling sites, the activity of the gaseous iodine fraction trapped on activated charcoal was significantly higher than that of the aerosol fraction captured on Petrianov filter cloth. The highest gaseous activity concentration was measured on 17 October 2016 in the air of the “hot room” (492 ± 4 Bq m−3). On that day, tablets with radioactive iodine were delivered and prepared for patients. The lowest gaseous activity concentration was measured on 23 October 2016 (28 ± 1 Bq m−3), 1 day before the next delivery of radioiodine tablets. The aerosol activity concentration in the air of the “hot room” was also slightly decreasing in the course of this week (from 7.2 ± 0.6 to 5.2 ± 0.3 Bq m−3). Gaseous activity concentrations measured in the air of the nurse station were on a similar level during the whole study period, and ranged from 146 ± 2 to 208 ± 3 Bq m−3 with a mean value of 174 ± 25 Bq m−3. Because the nurse station is located on the corridor next to the patients’ rooms and because there is no correlation between iodine delivery and activity variations, the measured mean activity concentration probably represents the average activity concentration of 131I in the air of corridor and patients’ rooms. For details, see Table 3.

Table 3

Measured 131I air activity concentrations in the air; given uncertainties represent measurement error calculated from one sigma counting statistics



131I activity concentration, gas fraction (Bq m−3)

131I activity concentration, aerosol fraction (Bq m−3)

“Hot room”

17 October 2016

492 ± 4

7.2 ± 0.6

20 October 2016

280 ± 3

6.2 ± 0.6

21 October 2016

42 ± 1

6.1 ± 0.5

22 October 2016

34 ± 1

5.2 ± 0.3

23 October 2016

28 ± 1

5.7 ± 0.4

Nurse station

18 November 2016

171 ± 2

18 ± 1

21 November 2016

173 ± 3

40 ± 1

22 November 2016

208 ± 3

8.5 ± 0.9

23 November 2016

146 ± 2

6.9 ± 0.9


174 ± 25

18 ± 15

On the basis of the results obtained for 131I air activity concentrations, radiation doses from inhalation of 131I were estimated. It turned out that the doses received from inhalation of the 131I aerosol fraction were significant smaller than those received from the 131I gas fraction, and can be neglected. For the gaseous fraction, estimated effective annual doses received by the medical staff varied between 0.47 mSv (nurse, female) and 1.3 mSv (technician, male). In general, doses for females were lower than those for males. The resulting effective and equivalent doses are shown in Table 4.

Table 4

Calculated annual organ equivalent and effective doses (given in Sv)



Effective dose

Gas fraction



3.2 × 10−2

1.3 × 10−3


2.7 × 10−2

1.1 × 10−3


3.0 × 10−2

1.2 × 10−3



1.3 × 10−2

5.4 × 10−4


1.1 × 10−2

4.7 × 10−4


1.2 × 10−2

5.0 × 10−4

Aerosol fraction



2.5 × 10−4

1.0 × 10−5


2.0 × 10−4

8.0 × 10−6


2.2 × 10−4

9.0 × 10−6



7.8 × 10−4

3.2 × 10−5


6.0 × 10−4

2.4 × 10−5


6.9 × 10−4

2.8 × 10−5

The highest doses were calculated for technicians working in the “hot room”. The effective annual doses for this group reached 1.1 and 1.3 mSv, respectively, for females and males. In contrast, for nurses, annual effective doses were about two times smaller (0.47 mSv for females and 0.54 mSv for males), as one might expect that the highest annual equivalent organ doses were found for the thyroid. Equivalent thyroid doses calculated for male technicians, female technicians, male nurses, and female nurses were 32, 27, 13, and 11 mSv, respectively.

Calculated effective doses are much lower than the corresponding dose limits included in Polish and European law regulations, which are limiting effective dose from occupational exposure to 20 mSv per year. They are also lower than the effective dose from natural background radiation in Poland which is 2.48 mSv per year (similar to the worldwide average exposure 2.4 mSv per year) (Janik and Tokonami 2009). However, the equivalent dose for the thyroid due to the Chernobyl accident estimated for a reference Polish inhabitant was equal to 45 mSv (Pietrzak-Flis et al. 2003), which means that a technician administering iodine accumulates over his professional career (30 years) a dose which is about 20 times higher than the dose from the Chernobyl accident.

The thyroid activities calculated in the present work based on the 131I air activity concentration and a biokinetic model were also compared to those measured in a previous study (Brudecki et al. 2017a). The results of this comparison are shown in Table 5. The best match was obtained for technicians, for whom the thyroid activity calculated in the present study is three-to-four times higher than that measured by Brudecki et al. 2017a. In contrast, for nurses, the calculated activity is about one order of magnitude larger than that measured. Both thyroid and air measurements were done during the normal work of the whole department. However, in the present study, air measurements were done only during 1 week for each workplace, and 131I activity concentrations in the air may change substantially depending on the number of patients treated. Moreover, a single exposure time of 6 h was assumed in the present work for technicians and 12 h for nurses, which represent average work times; this assumption may also contribute to the uncertainties of the doses calculated here. To reduce these uncertainties, exposure times should be monitored individually, for example, using motion detectors (Hoi et al. 2016). In addition, technicians work under similar conditions throughout the year, while nurses in the department work 3 months a year, and then they are rotated to other departments, which can influence the dose estimates.

Table 5

Comparison between measured and calculated thyroid activities


Simulated thyroid activity (Bq)

Measured thyroid activity (Brudecki et al. 2017a) (Bq)






from < 5 to 66 ± 17




217 ± 56



107 ± 28


Up to now, internal doses were not considered important in Polish nuclear medicine facilities. Consequently, workers are only monitored for exposure to external radiation fields using TLD dosimeters. These measurements give no information about the radiation dose from incorporated radioiodine. The results obtained in the present work suggest that periodic and systematic checks and measurements of internal contamination should be an integral part of the radiation protection of staff working with high activities of 131I.

The method described here to monitor radiation doses from incorporated radioiodine has some drawbacks. For example, the proposed method needs a sampling station including an HPGe detector which is expensive, and it will be difficult to perform constant monitoring by hospital personnel. In addition, averaging of exposure time may represent a significant source of uncertainties in dose estimation, which should be improved by individual time monitoring.

However, despite these disadvantages, the presented method can successfully be used to monitor internal doses from incorporated radioiodine. The method has a lot of advantages. For example, collection time is relatively short (minutes or hours) which means that in a short period of time, it is possible to collect many samples from different locations. Furthermore, measurements can be carried out onsite, which does not influence nuclear medicine facility staff in fulfilling their duties. Moreover, this method has already been successful used for many years to monitor radioactive contamination in the air at places of serious nuclear accidents. It is concluded that there are no reasons not to use it also in nuclear medicine. In practice, instead of computer modeling, ICRP dose conversion factors can be used. This will significantly simplify and speed up the dose calculations.



This study was funded by the National Science Centre, Poland (Grant Number 2014/15/B/NZ7/00925).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights

This article does not contain any studies with human and animals performed by any of the authors.


  1. Brudecki K, Li WB, Meisenberg O, Tschiersch J, Hoeschen C, Oeh U (2014) Age-dependent inhalation doses to members of the public from indoor short-lived radon progeny. Radiat Environ Biophys 53:535–549CrossRefGoogle Scholar
  2. Brudecki K, Kowalska A, Zagrodzki P, Szczodry A, Mroz T, Janowski P, Mietelski JW (2017a) Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital. Radiat Environ Biophys 56(1):19–26CrossRefGoogle Scholar
  3. Brudecki K, Szufa K, Mietelski JW (2017b) 131I age-dependent inhalation dose in Southern Poland from Fukushima accident. Radiat Environ Biophys 56(1):9–17CrossRefGoogle Scholar
  4. Ferdous J, Shramin N, Begum A, Begum A (2017) Airborne radioactivity in hot lab of nuclear medicine. J Sci Res 9:159–166CrossRefGoogle Scholar
  5. Hoi TX, Phuong HT, Hung NV (2016) Using smartphone as a motion detector to collect time-microenvironment data for estimating the inhalation dose. Appl Radiat Isot 115:267–273CrossRefGoogle Scholar
  6. Hoi TX, Phuong HT, Hung NV (2017) Estimating the internal dose for 131I production workers from air sampling method. Radiat Prot Dosim 175(1):58–64Google Scholar
  7. IAEA (1999) International Atomic Energy Agency. Assessment of occupational exposure due to intakes of radionuclides. Safety standard series RS-G-1.2, ViennaGoogle Scholar
  8. Ibis E, Wilson CR, Collier BD, Akansel G, Istiman AT, Yoss RG (1992) Iodine-131 contamination from thyroid cancer patients. J Nucl Med 33:2110–2115Google Scholar
  9. ICRP (1979) International Commission of Radiological Protection. Limits for intakes of radionuclides by workers. Part 1. ICRP Publication 30. Ann ICRP 2(3–4). Pergamon, OxfordGoogle Scholar
  10. ICRP (1994) International Commission of Radiological Protection. The human respiratorytract model for radiological protection. ICRP Publication 66. Ann ICRP 24(1–3). Pergamon, OxfordGoogle Scholar
  11. ICRP (1995) International Commission on Radiological Protection. Age-dependent doses to members of the public from intake of radionuclides: Part 4. Inhalation dose coefficients. ICRP Publication 71. Ann ICRP 25(3–4). Pergamon, OxfordGoogle Scholar
  12. ICRP (1997) International Commission on Radiological Protection. Individual monitoring for internal exposure of workers (preface and glossary missing). ICRP Publication 78. Ann ICRP 27(3–4). Pergamon, OxfordGoogle Scholar
  13. ICRP (2002) International Commission of Radiological Protection. Guide for the practical application of the ICRP human respiratory tract model. ICRP Supporting Guidance, vol 3. Pergamon, OxfordGoogle Scholar
  14. ICRP (2007) International Commission of Radiological Protection. The 2007 recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37(2–4)Google Scholar
  15. Janik M, Tokonami S (2009) Natural and artificial sources of radioactivity in Poland. Jpn J Health Phys 44:116–121CrossRefGoogle Scholar
  16. Jiemwutthisak P, Sritongkul N, Chaudakshetrin P, Kanchanaphiboon P, Tuntawiroon M (2012) Air monitoring to control the intake of airborne radioiodine-131 contaminants by nuclear medicine workers. In: 6th annual scientific meeting on challenges of quality assurance in radiation medicine, PhitsanulokGoogle Scholar
  17. Leggett RW (2010) A physiological systems model for iodine for use in radiation protection. Radiat Res 174:496–516ADSCrossRefGoogle Scholar
  18. Li WB, Tschiersch J, Oeh U, Hoeschen C (2008) Lung dosimetry of inhaled thoron decay products. In: 12th international congress of IRPA 2008, 19–24 October 2008, Buenos AiresGoogle Scholar
  19. Masson O, Baeza A, Bieringer J, Brudecki K, Bucci S, Cappai M, Carvalho FP, Connan O, Cosma C, Dalheimer A, Didier D, Depuydt G, De Geer LE, De Vismes A, Gini L, Groppi F, Gudnason K, Gurriaran R, Hainz D, Halldórsson O, Hammond D, Hanley O, Holeý K, Homoki Z, Ioannidou A, Isajenko K, Jankovic M, Katzlberger C, Kettunen M, Kierepko R, Kontro R, Kwakman PJM, Lecomte M, Leon Vintro L, Leppänen AP, Lind B, Lujaniene G, Mc Ginnity P, Mc Mahon C, Malá H, Manenti S, Manolopoulou M, Mattila A, Mauring A, Mietelski JW, Møller B, Nielsen SP, Nikolic J, Overwater RMW, Pálsson SE, Papastefanou C, Penev I, Pham MK, Povinec PP, Ramebäck H, Reis MC, Ringer W, Rodriguez A, Rulík P, Saey PRJ, Samsonov V, Schlosser C, Sgorbati G, Silobritiene BV, Söderström C, Sogni R, Solier L, Sonck M, Steinhauser G, Steinkopff T, Steinmann P, Stoulos S, Sýkora I, Todorovic D, Tooloutalaie N, Tositti L, Tschiersch J, Ugron A, Vagena E, Vargas A, Wershofen H, Zhukova O (2011) Tracking of airborne radionuclides from the damaged Fukushima Dai-ichi nuclear reactors by European networks. Environ Sci Technol 45:7670–7677ADSCrossRefGoogle Scholar
  20. Mietelski JW, Grabowska S, Nowak T, Bogacz J, Gaca P, Bartyzel M, Budzanowski M (2005) Inhalation dose due to presence of 131I in air above septic tank system of an endocrinology hospital. Radiat Prot Dosim 117(4):395–340CrossRefGoogle Scholar
  21. Mietelski JW, Kierepko R, Brudecki K, Janowski P, Kleszcz K, Tomankiewicz E (2014) Long-range transport of gaseous 131I and other radionuclides from Fukushima accident to Southern Poland. Atmos Environ 91:137–145ADSCrossRefGoogle Scholar
  22. Mietelski JW, Nalichowska E, Tomankiewicz E, Brudecki K, Janowski P, Kierepko R (2017) Gamma emitters in atmospheric precipitation in Krakow (Southern Poland) during the years 2005–2015. J Environ Radioact 166:10–16CrossRefGoogle Scholar
  23. Pietrzak-Flis Z, Krajewski P, Radwan I, Muramatsu Y (2003) Retrospective evaluation of 131I deposition density and thyroid dose in Poland after the Chernobyl accident. Health Phys 84:698–708CrossRefGoogle Scholar
  24. Wangchang L, Yuying H, Yianwei W, Ming J, Liangtian G (1993) Research on removal of radioiodine by charcoal. In: L/ILW management and final disposal proceedings, China, p 294Google Scholar
  25. Wilhelm JG (1982) Iodine filters in nuclear installations. Commission of the European Communities, LuxemburgGoogle Scholar

Copyright information

© The Author(s) 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • K. Brudecki
    • 1
    Email author
  • A. Szczodry
    • 2
  • T. Mróz
    • 3
  • A. Kowalska
    • 2
  • J. W. Mietelski
    • 1
  1. 1.Institute of Nuclear PhysicsPolish Academy of SciencesKrakowPoland
  2. 2.Department of Endocrinology and Nuclear Medicine Holycross Cancer CenterKielcePoland
  3. 3.Pedagogical University in CracowKrakowPoland

Personalised recommendations